Thevarajan et al. showed that activated CD8+HLA–DR+CD38+ T cells in a mild case of COVID-19 significantly expand following symptom onset, reaching their peak frequency of 12% of CD8+ T cells on day 9 after symptom onset, and contract thereafter (Thevarajan et al., 2020). This evidence concerns the gene CD8A and COVID-19.